Preoperative Prognostic Score for Predicting Survival After Hepatic Resection for Colorectal Liver Metastases

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Annals of Surgery

• Publication date

  2007-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/SLA.0b013e318142d964PMID 17968173
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic influence of multiple hepatic metastases from colorectal cancer.

  2007influential reference
• A prospective study of serum C-reactive protein and colorectal cancer risk in men.

  2006cited by this paper
• Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule.

  2006cited by this paper
• Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases.

  2006cited by this paper
• An audit of fusion CT-PET in the management of colorectal liver metastases.

  2006influential reference
• Hepatic arterial infusion (HAI). Comparison of 5-fluorouracil, folinic acid, interferon alpha-2b and degradable starch microspheres versus 5-fluorouracil and folinic acid in patients with non-resectable colorectal liver metastases.

  2006cited by this paper
• Surgical resection of hepatic metastases from colorectal cancer: A systematic review of published studies

  2006cited by this paper
• Antiangiogenic activity of the selective cyclooxygenase 2 inhibitor rofecoxib in human colorectal cancer liver metastases

  2006cited by this paper
• Effect of Surgical Margin Status on Survival and Site of Recurrence After Hepatic Resection for Colorectal Metastases

  2005cited by this paper
• Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging.

  2005cited by this paper
• Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.

  2005cited by this paper
• Liver resection after irinotecan, 5-fluorouracil, and folinic acid for patients with unresectable colorectal liver metastases

  2005cited by this paper
• Serum levels of VEGF and TNF-α and their association with C-reactive protein in patients with endometriosis

  2005influential reference
• The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer

  2005cited by this paper
• Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases.

  2005cited by this paper
• Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results

  2005cited by this paper
• Neutrophil‐lymphocyte ratio as a prognostic factor in colorectal cancer

  2005cited by this paper
• Quality of life in patients with liver cancer after operation: a 2-year follow-up study.

  2004cited by this paper
• Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection.

  2004cited by this paper
• Tumor Progression While on Chemotherapy: A Contraindication to Liver Resection for Multiple Colorectal Metastases?

  2004cited by this paper
• Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases

  2004cited by this paper
• Platelets and Granulocytes, in Particular the Neutrophils, Form Important Compartments for Circulating Vascular Endothelial Growth Factor

  2004cited by this paper
• Value of integrated PET/CT for lesion localisation in cancer patients: a comparative study

  2004cited by this paper
• Five-Year Survival After Resection of Hepatic Metastases From Colorectal Cancer in Patients Screened by Positron Emission Tomography With F-18 Fluorodeoxyglucose (FDG-PET)

  2004cited by this paper
• Liver resection for colorectal metastases.

  2003cited by this paper
• The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases.

  2003cited by this paper
• Therapeutic Results for Hepatic Metastasis of Colorectal Cancer With Special Reference to Effectiveness of Hepatectomy: Analysis of Prognostic Factors for 763 Cases Recorded at 18 Institutions

  2003cited by this paper
• Laboratory variables to stratify metastatic colorectal cancer patients.

  2003cited by this paper
• Lymphocytic infiltration surrounding liver metastases from colorectal cancer

  2003influential reference
• Liver resection for colorectal metastases.

  2003cited by this paper
• Systemic inflammatory response predicts survival following curative resection of colorectal cancer

  2003cited by this paper
• The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.

  2003cited by this paper
• Hepatic resection for colorectal liver metastases: prospective study.

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases

  2002cited by this paper
• Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients.

  2002cited by this paper
• FDG-PET improves the staging and selection of patients with recurrent colorectal cancer

  2002cited by this paper
• Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma.

  2001cited by this paper
• Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer.

  2001cited by this paper
• A historic perspective of liver surgery for tumors at the end of the millennium.

  2001cited by this paper
• Surgical resection of colorectal liver metastases

  2001cited by this paper
• Inflammation and cancer: back to Virchow?

  2001cited by this paper
• Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal.

  2001cited by this paper
• Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases

  2001cited by this paper
• Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection.

  2000cited by this paper
• IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1.

  2000cited by this paper
• Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma

  2000cited by this paper
• Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial.

  2000cited by this paper
• Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

  2000cited by this paper
• Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

  2000cited by this paper
• Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

  1999influential reference
• Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery.

  1999cited by this paper
• Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer.

  1998cited by this paper
• Resection of Colorectal Liver Metastases: 25-Year Experience

  1998cited by this paper
• Hepatic resection for metastatic colorectal cancer results in cure for some patients.

  1997cited by this paper
• Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma.

  1997cited by this paper
• Late results justify resection for multiple hepatic metastases from colorectal cancer

  1997cited by this paper
• Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy.

  1996cited by this paper
• A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery.

  1995cited by this paper
• Pattern of recurrence after hepatic resection for colorectal metastases

  1993cited by this paper
• A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584.

  1991cited by this paper
• Indicators of prognosis after hepatic resection for colorectal secondaries.

  1991cited by this paper
• Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment.

  1989cited by this paper
• [Inflammation and cancer].

  1974cited by this paper
• Factors influencing survival in patients with untreated hepatic metastases.

  1968cited by this paper
• [Liver lobes and segments: notes on the anatomical architecture and surgery of the liver ].

  1954cited by this paper
• [Not Available].

  1946cited by this paper

• A machine learning-based prognostic stratification of locoregional interventional therapies for patients with colorectal cancer liver metastases: a real-world study

  2025cites this paper
• HOXA13 overexpression is associated with poor prognosis in colorectal liver metastases

  2025cites this paper
• Validation of tumor burden score as a prognostic factor in colorectal cancer liver metastases patients: a retrospective analysis

  2025cites this paper
• Surgical outcome and risk scoring to predict survival after hepatic resection for hepatocellular carcinoma with portal vein tumor thrombosis

  2024cites this paper
• Clinical Prediction Models for Prognosis of Colorectal Liver Metastases: A Comprehensive Review of Regression-Based and Machine Learning Models

  2024cites this paper
• The predictive value of perioperative circulating markers on surgical complications in patients undergoing robotic-assisted radical prostatectomy

  2023cites this paper
• The Role of Stereotactic Body Radiation Therapy in the Management of Liver Metastases.

  2023cites this paper
• Ranking as a Procedure for Selecting a Replacement Variable in the Score Predicting the Survival of Patients Treated with Curative Intent for Colorectal Liver Metastases

  2023cites this paper
• Predictive preoperative clinical score for patients with liver-only oligometastatic colorectal cancer

  2022cites this paper
• The Significance of Neutrophil Extracellular Traps in Colorectal Cancer and Beyond: From Bench to Bedside

  2022cites this paper
• Taiwan Society of Colon and Rectum Surgeons (TSCRS) Consensus for Anti-Inflammatory Nutritional Intervention in Colorectal Cancer

  2022cites this paper
• Prediction of survival in patients with colorectal liver metastases- development and validation of a prognostic score model.

  2022cites this paper
• Machine Learning Approach to Stratifying Prognosis Relative to Tumor Burden after Resection of Colorectal Liver Metastases: An International Cohort Analysis.

  2022cites this paper
• Prognostic factors in colorectal liver metastases patients with various tumor numbers treated by liver resection: a single-center, retrospective study

  2022cites this paper
• A blood-based noninvasive miRNA signature for predicting survival outcomes in patients with intrahepatic cholangiocarcinoma

  2022cites this paper
• The prognostic value of elevated neutrophil–lymphocyte ratio for cardiac surgery‐associated acute kidney injury: A systematic review and meta‐analysis

  2022cites this paper
• Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status.

  2021cites this paper
• Proposal of a novel H category‐based classification of colorectal liver metastases based on a Japanese nationwide survey

  2021cites this paper
• Identification and Validation of a Novel Inflammatory Response-Related Gene Signature for the Prognosis of Colon Cancer

  2021cites this paper
• Effect of tumour size ratio on liver recurrence-free survival of patients undergoing hepatic resection for colorectal liver metastases

  2021cites this paper
• Neoadjuvant and Adjuvant Therapy for Cholangiocarcinoma

  2021cites this paper
• IRANIAN JOURNAL OF VETERINARY SURGERY

  2020cites this paper
• Impact of type and severity of postoperative complications on long‐term outcomes after colorectal liver metastases resection

  2020cites this paper
• Changes in urinary bladder structure and systemic inflammation response following incomplete transection versus contusion spinal cord injury in rat model

  2020cites this paper
• Size of the Largest Colorectal Liver Metastasis Is an Independent Prognostic Factor in Neoadjuvant Setting.

  2020cites this paper
• Colorectal Liver Metastasis: Current Concepts

  2020cites this paper
• Combination of Haemoglobin and Prognostic Nutritional Index Predicts the Prognosis of Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma

  2020cites this paper
• Computed tomography-measured bone mineral density as a surrogate marker of survival after resection of colorectal liver metastases

  2020cites this paper
• Neutrophil-to-Lymphocyte Ratio and Intratumoral CD45RO-Positive T Cells as Predictive Factors for Longer Survival of Patients with Colorectal Liver Metastasis after Hepatectomy.

  2020cites this paper
• CMAR_A_266821 8589..8597

  2020cites this paper
• The impact of posthepatectomy liver failure on long-term survival after hepatectomy for colorectal liver metastasis.

  2019cites this paper
• Resection of Metachronous Colorectal Cancer Liver Metastases: Surgical Outcomes

  2019cites this paper
• Comparison of Models for Tumor Recurrence after Liver Transplantation for the Patients with Hepatocellular Carcinoma: A Multicenter Long-Term Follow-Up Study

  2019cites this paper
• Clinical Scoring Systems for Colorectal Cancer Liver Metastases

  2019cites this paper
• Survival Benefit of and Indications for Adjuvant Chemotherapy for Resected Colorectal Liver Metastases—a Japanese Nationwide Survey

  2019cites this paper
• Defining Resectability of Colorectal Cancer Liver Metastases: Technical and Oncologic Perspectives

  2019cites this paper
• Staging Classifications of Colorectal Liver Metastases

  2019cites this paper
• Significance of the inflammation-based prognostic score in recurrent pancreatic cancer.

  2019cites this paper
• Neutrophil Extracellular Traps and Liver Disease

  2019cites this paper
• Prognostic factors for survival in stage IV rectal cancer: A Swedish nationwide case-control study.

  2019cites this paper
• Effects of anesthetic technique and surgery on myeloid-derived suppressor cells and prognosis in women who underwent breast cancer surgery: a prospective study

  2019cites this paper
• A clinical‐radiomic model for improved prognostication of surgical candidates with colorectal liver metastases

  2019cites this paper
• Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable

  2019cites this paper
• Evaluation of the relationship between neutrophil lymphocyte ratio and the most common bacterial urinary tract infections after transplantation.

  2019cites this paper
• Neutrophil/Lymphocyte Ratio in Patients Undergoing Noncardiac Surgery After Coronary Stent Implantation.

  2019cites this paper
• CMAR_A_183519 5513..5522

  2019cites this paper
• Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial – PACHA-01 (NCT02494973)

  2018cites this paper
• Neutrophils and neutrophil extracellular traps in the liver and gastrointestinal system

  2018cites this paper
• A Low Neutrophil to Lymphocyte Ratio Before Preoperative Chemotherapy Predicts Good Outcomes After the Resection of Colorectal Liver Metastases

  2018cites this paper
• Thymidylate synthase: a predictive biomarker in resected colorectal liver metastases receiving 5-FU treatment.

  2018cites this paper
• Topics related to neoadjuvant chemotherapy for resectable liver metastases from colorectal cancer.

  2018cites this paper
• Proposal of Two Prognostic Models for the Prediction of 10-Year Survival after Liver Resection for Colorectal Metastases

  2018cites this paper
• Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer?

  2018cites this paper
• The Tumor Burden Score: A New “Metro-ticket” Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors

  2018cites this paper
• Patient Selection and Guidelines for Resection and Liver-Directed Therapies: Non-colorectal, Non-neuroendocrine Liver Metastases

  2018cites this paper
• An Overview on Hepatic Metastasis

  2017cites this paper
• Remnant Liver Ischemia as a Prognostic Factor for Cancer-Specific Survival After Resection of Colorectal Liver Metastases

  2017cites this paper
• Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer

  2017cites this paper
• Análisis de la expresión de PLK1 como factor pronóstico y predictor de respuesta a tratamiento quimioterápico en carcinoma colo-rectal metastásico

  2017cites this paper
• A Novel Biomarker-Based Preoperative Prognostic Grading System for Predicting Survival After Surgery for Intrahepatic Cholangiocarcinoma

  2017cites this paper
• Liver metastases: Basic principles of treatment and clinical data

  2017cites this paper
• Neutrophil Extracellular Trap Production in Patients with Colorectal Cancer In Vitro

  2017cites this paper
• of Birmingham Neutrophil Extracellular Trap Production in Patients with Colorectal Cancer In Vitro

  2017cites this paper
• Characterization of systemic neutrophil function in patients undergoing colorectal cancer resection.

  2017cites this paper
• Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.

  2017influential citation
• Precision surgery for colorectal liver metastases: Opportunities and challenges of omics-based decision making.

  2017cites this paper
• Repeat hepatectomy is independently associated with favorable long‐term outcome in patients with colorectal liver metastases

  2017cites this paper
• Comprehensive Complication Index Predicts Cancer-specific Survival After Resection of Colorectal Metastases Independent of RAS Mutational Status

  2017cites this paper
• Personalizing prognosis in colorectal cancer: A systematic review of the quality and nature of clinical prognostic tools for survival outcomes

  2017cites this paper
• Preoperative peripheral blood neutrophil count predicts long-term outcomes following hepatic resection for colorectal liver metastases.

  2017cites this paper
• Introduction of the resection severity index as independent risk factor limiting survival after resection of colorectal liver metastases.

  2017cites this paper
• RAS Mutation Clinical Risk Score to Predict Survival After Resection of Colorectal Liver Metastases

  2017cites this paper
• Update on current problems in colorectal liver metastasis.

  2017cites this paper
• Recurrence After Liver Transplantation for Hepatocellular Carcinoma: A New MORAL to the Story

  2017cites this paper
• Preoperative Risk Score and Prediction of Long-Term Outcomes after Hepatectomy for Intrahepatic Cholangiocarcinoma.

  2017influential citation
• Neutrophil‐to‐lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma

  2017cites this paper
• Centralization of Liver Cancer Surgery and Impact on Multidisciplinary Teams Working on Stage IV Colorectal Cancer

  2017cites this paper
• CPEB4 immunohistochemical expression is associated to prognosis in stage IV colorectal carcinoma.

  2017cites this paper
• Impact of the C-reactive protein to albumin ratio on long-term outcomes after hepatic resection for colorectal liver metastases.

  2017cites this paper
• Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection.

  2016cites this paper
• The Tumor Burden Score A New ‘ ‘ Metro-ticket ’ ’ Prognostic Tool For Colorectal Liver Metastases Based on umber of Tumors Tumor Size and N

  2016cites this paper
• Pattern of tumour growth of the primary colon cancer predicts long-term outcome after resection of liver metastases

  2016influential citation
• A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma.

  2016cites this paper
• A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases

  2016cites this paper
• Glasgow Prognostic Score may be a prognostic index for overall and perioperative survival in gastric cancer without perioperative treatment.

  2016cites this paper
• Carcinoembryonic Antigen as a Prognostic Factor in Colorectal Cancer with Liver Metastases

  2015cites this paper
• Prognostic Factors after Liver Resection for Colorectal Liver Metastasis.

  2015cites this paper
• Positive Postoperative CEA is a Strong Predictor of Recurrence for Patients After Resection for Colorectal Liver Metastases

  2015cites this paper
• Association of the Preoperative Neutrophil-to-ymphocyte Count Ratio and Platelet-to-Lymphocyte Count Ratio with Clinicopathological Characteristics in Patients with Papillary Thyroid Cancer

  2015cites this paper
• Changes in neutrophil/lymphocyte and platelet/lymphocyte ratios after chemotherapy correlate with chemotherapy response and prediction of prognosis in patients with unresectable gastric cancer

  2015cites this paper
• Factors Predicting Response to Neoadjuvant Therapy of Hepatic Metastasis from Colorectal Carcinoma

  2015cites this paper
• Recurrence of hepatocellular carcinoma after liver transplantation: an update.

  2015cites this paper
• Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents

  2015cites this paper
• Meta‐analysis of KRAS mutations and survival after resection of colorectal liver metastases

  2015cites this paper
• Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer

  2015cites this paper
• C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review

  2015cites this paper
• Postoperative Complications Affect Long-Term Survival Outcomes Following Hepatic Resection for Colorectal Liver Metastasis

  2015cites this paper
• SMAD4 and TS expression might predict the risk of recurrence after resection of colorectal liver metastases

  2015cites this paper
• Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery.

  2015cites this paper
• The role of prognostic models in metastatic colorectal liver cancer surgery.

  2015cites this paper